Visits: 1552, Avg visit time (secs): 270,10 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 725 | 46,71% | |
| /programmes.html | 205 | 13,21% |
| /home.html | 67 | 4,32% |
| /pfizer/efsd-pfizer-rfa08.html | 52 | 3,35% |
| /msd/albert-renold/efsd-msd-arenold.html | 47 | 3,03% |
| /lifescan/efsd-lifescan-rfa08.html | 38 | 2,45% |
| /novartis/efsd-novartis-rfa09.html | 34 | 2,19% |
| /amylin/efsd-amylin-rfa08.html | 30 | 1,93% |
| /gsk/efsd-gsk-rfa08.html | 21 | 1,35% |
| /regulations.html | 21 | 1,35% |
| /lilly/fellowships/efsd-lilly-fship08.html | 18 | 1,16% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 759 | 48,90% |
| /lifescan/efsd-lifescan-rfa08.html | 144 | 9,28% |
| /gsk/efsd-gsk-rfa08.html | 52 | 3,35% |
| /lilly/fellowships/efsd-lilly-fship08.html | 44 | 2,84% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa08.html | 36 | 2,32% |
| /msd/albert-renold/efsd-msd-arenold.html | 35 | 2,26% |
| /home.html | 34 | 2,19% |
| /lilly/programme/efsd-cds-lilly-rfa08.html | 33 | 2,13% |
| /amylin/efsd-amylin-rfa08.html | 30 | 1,93% |
| /programmes.html | 29 | 1,87% |
| /pfizer/efsd-pfizer-rfa08.html | 26 | 1,68% |